You have 9 free searches left this month | for more free features.

AMD

Showing 1 - 25 of 1,303

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

Not yet recruiting
  • Age Related Macular Degeneration (AMD)
  • SPIN
  • Non-aerobic, stretching/balance intervention Control
  • Decatur, Georgia
    Atlanta VA Medical and Rehab Center, Decatur, GA
Jun 26, 2023

Sinusitis inSingle-center Prospective Cohort of Exudative AMD

Recruiting
  • AMD
  • sinusitis screening consultation
  • Paris, France
    Hôpital Fondation A. de Rothschild
Jan 23, 2023

Ocular, Vascular, and Genetic Findings in AMD Patients

Recruiting
  • Age-Related Macular Degeneration
  • No intervention
  • Tel Aviv, Israel
    Tel Aviv Sourasky Medical Center
Aug 23, 2023

A Collaborative Resource of Heidelberg Multimodal Imaging of

Not yet recruiting
  • Age Related Macular Degeneration
  • +3 more
  • Collection of both retrospective and prospective data collection in 3 visits.
  • (no location specified)
Jan 16, 2023

Impact of Non-Exudative Type 1 MNV on AMD Progression

Recruiting
  • Age-Related Macular Degeneration
  • Neovascularization, Choroidal
    • Salt Lake City, Utah
      University of Utah
    Nov 15, 2023

    AMD Ryan Initiative Study (ARIS)

    Completed
    • Age-Related Macular Degeneration
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 30, 2023

      Age-Related Macular Degeneration (ARMD) Trial in Coimbra (Blood draw)

      Not yet recruiting
      • Age-Related Macular Degeneration (ARMD)
      • Blood draw
      • Coimbra, Portugal
        AIBILI-CEC (AIBILI- Clinical Trials Centre)
      Feb 9, 2023

      Macular Degeneration Trial in Bordeaux (MacuTest platform)

      Not yet recruiting
      • Macular Degeneration
      • MacuTest platform
      • Bordeaux, France
        CHU Bordeaux
      Dec 28, 2022

      Macular Degeneration, Age Related, Cataract Trial (NGenuity)

      Not yet recruiting
      • Macular Degeneration, Age Related
      • Cataract
      • NGenuity
      • (no location specified)
      Aug 3, 2023

      CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea

      Active, not recruiting
      • AMD
      • Exudative Macular Degeneration
        • Bordeaux, France
        • +4 more
        Dec 2, 2022

        Macular Degeneration (AMD) Post-marketing Surveillance in Japan

        Completed
        • Macular Degeneration
        • Aflibercept(Eylea, VEGF Trap-Eye, BAY86-5321)
        • Multiple Locations, Japan
          (unnamed)
        Jan 9, 2023

        Age-Related Macular Degeneration and Its Progression

        Recruiting
        • Age Related Macular Degeneration
        • +3 more
        • N/A Observational study
        • East Melbourne, Victoria, Australia
          Centre for Eye Research Australia
        Jul 20, 2022

        OCT Angiography in Wet AMD

        Recruiting
        • Neovascular (Wet) Age-related Macular Degeneration (AMD)
        • Optical Coherence Tomography
        • Portland, Oregon
          Casey Eye Institute, Oregon Health & Science University
        Sep 20, 2022

        Age-Related Macular Degeneration Trial (Active Comparator CT1812, Placebo Comparator)

        Not yet recruiting
        • Age-Related Macular Degeneration
        • Active Comparator CT1812
        • Placebo Comparator
        • (no location specified)
        Jun 5, 2023

        Subjects Diagnosed With Neovascular-AMD

        Recruiting
        • Retinal Neovascularization
          • Boston, Massachusetts
          • +2 more
          Dec 6, 2022

          VeriSee AMD in Screening for Age-Related Macular Degeneration

          Completed
          • Macular Degeneration, Age Related
          • Maculopathy, Age Related
            • Taipei, Taiwan
              National Taiwan University Hospital
            Oct 23, 2022

            Dry Age-related Macular Degeneration Trial in Rome (Intravitreal injection of CB-PRP)

            Recruiting
            • Dry Age-related Macular Degeneration
            • Intravitreal injection of CB-PRP
            • Rome, Italy
              Fondazione Policlinico Universitario Agostino Gemelli IRCCS
            Jan 23, 2023

            Neovascular Age-related Macular Degeneration Trial (Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule,

            Not yet recruiting
            • Neovascular Age-related Macular Degeneration
            • Intravitreal injections of 6 mg faricimab on a Treat and Extend schedule
            • Intravitreal injections of 6 mg faricimab on a home optical coherence tomography-guided treatment schedule
            • (no location specified)
            Jun 6, 2023

            Age-Related Macular Degeneration Trial in Hong Kong (Brolucizumab, Aflibercept)

            Recruiting
            • Age-Related Macular Degeneration
            • Hong Kong, Hong Kong
              Grantham Hospital
            Jan 25, 2023

            Progression of Early Atrophic Lesions

            Not yet recruiting
            • Age-Related Macular Degeneration
            • No intervention
            • Salt Lake City, Utah
              University of Utah
            Jul 26, 2023

            Dry Age-related Macular Degeneration Trial (QA102/Placebo, QA102, Placebo)

            Not yet recruiting
            • Dry Age-related Macular Degeneration
            • QA102/Placebo
            • +2 more
            • (no location specified)
            Sep 8, 2022

            Dry Age-related Macular Degeneration Trial in Ann Arbor (RPESC-RPE-4W)

            Recruiting
            • Dry Age-related Macular Degeneration
            • RPESC-RPE-4W
            • Ann Arbor, Michigan
              University of Michigan Kellogg Eye Center
            Jan 27, 2023

            Age-Related Macular Degeneration Trial (Bevacizumab-IRDye800CW, Vedolizumab-IRDye800CW)

            Not yet recruiting
            • Age-Related Macular Degeneration
            • (no location specified)
            May 19, 2022

            Validation of Bulbicam for DR- and AMD-patients

            Not yet recruiting
            • Diabetic Retinopathy
            • Age-Related Macular Degeneration
            • BulbiCam
            • (no location specified)
            Jun 27, 2022

            Preparation of Patient Autologous Induced Pluripotent Stem

            Not yet recruiting
            • Age-Related Macular Degeneration
            • somatic cell collection
            • (no location specified)
            Aug 14, 2023